Suzanne A. Eccles
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 19
- Oncology top 0.5%
- Cancer Cells and Metastasis 13
- HER2/EGFR in Cancer Research 13
- Molecular Biology top 1%
- Angiogenesis and VEGF in Cancer 13
- PI3K/AKT/mTOR signaling in cancer 12
- Heat shock proteins research 12
- Cell Biology top 1%
- Microtubule and mitosis dynamics 10
- Immunology and Allergy top 2%
-
- Monoclonal and Polyclonal Antibodies Research 12
- Co-authors
- Danny R. WelchCarol BoxPornchai O‐charoenratPeter Rhŷs‐EvansPeter AlexanderWilliam CourtMaria VinciSharon Gowan
- Journals
- Cancer Research (13 papers)Molecular Cancer Therapeutics (12 papers)International Journal of Cancer (9 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Suzanne A. Eccles
140 papers receiving 8.7k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Cancer Research 2.1k
- Oncology 3.5k
- Molecular Biology 5.1k
- Cell Biology 872
- Immunology and Allergy 303
Countries citing papers authored by Suzanne A. Eccles
This map shows the geographic impact of Suzanne A. Eccles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne A. Eccles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne A. Eccles more than expected).
Fields of papers citing papers by Suzanne A. Eccles
This network shows the impact of papers produced by Suzanne A. Eccles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne A. Eccles. The network helps show where Suzanne A. Eccles may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Suzanne A. Eccles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2020 | 20 | |
| 3 | 2017 | 32 | |
| 4 | 2017 | 8 | |
| 5 | 2016 | 16 | |
| 6 | 2015 | 89 | |
| 7 | 2013 | 110 | |
| 8 | 2012 | 69 | |
| 9 | 2011 | 41 | |
| 10 | 2011 | 67 | |
| 11 | 2010 | 59 | |
| 12 | 2010 | 62 | |
| 13 | 2010 | 63 | |
| 14 | 2009 | 92 | |
| 15 | Use of gene expression microarrays to identify novel pharmacodynamic biomarkers of phosphatidylinositide-3’-kinase (PI3K) inhibition | 2008 | 1 |
| 16 | 2007 | 65 | |
| 17 | 2007 | 36 | |
| 18 | Mechanism of action of a novel series of inhibitors of the Hsp90 molecular chaperone | 2004 | 1 |
| 19 | ErbB2 overexpression in an ovarian cancer cell line confers sensitivity to the HSP90 inhibitor geldanamycin. | 2002 | 44 |
| 20 | 1995 | 7 |
About Suzanne A. Eccles
Suzanne A. Eccles is a scholar working on Oncology, Cancer Research and Cell Biology, having authored 140 papers that have together received 8.9k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (19 papers), Cancer Cells and Metastasis (13 papers), HER2/EGFR in Cancer Research (13 papers), Angiogenesis and VEGF in Cancer (13 papers), PI3K/AKT/mTOR signaling in cancer (12 papers), Heat shock proteins research (12 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Microtubule and mitosis dynamics (10 papers). The work is most often cited by research in Cancer Research (2.1k citations), Oncology (3.5k citations) and Molecular Biology (5.1k citations). Suzanne A. Eccles has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Danny R. Welch, Carol Box, Pornchai O‐charoenrat, Peter Rhŷs‐Evans, Peter Alexander, William Court, Maria Vinci, Sharon Gowan, Miriam Zimmermann and Gary Box. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, International Journal of Cancer, Clinical Cancer Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.